Tıbbi Onkoloji

Uzm. Dr. Duygu Ercan Uzundal

Hekim ve araştırmacı Ankara Bilkent Şehir Hastanesi Ankara
Kurum sayfasını aç
Düzeltme öner

Bu sizin profiliniz mi? Sahiplenin, bilgilerinizi doğrulayın.

Profili sahiplen

Güven

Bu bilgiler nereden geliyor?

Her bilginin yanında kaynağı yazar. Yanlış bir şey görürseniz düzeltme önerebilirsiniz.

  • UzmanlıkTıbbi Onkolojisaglik.gov.trKaynaktan
  • KurumAnkara Bilkent Şehir Hastanesisaglik.gov.trKaynaktan
  • Yayınlar13 yayınOpenAlex, ORCIDKaynaktan
  • ORCID0000-0002-1277-8413ORCIDKaynaktan
  • Son eşitleme5 Kasım 2026 07:23https://ankarasehir.saglik.gov.tr/TR-331078/tibbi-onkoloji-klinigi-doktorlarimiz.html#duygu-ercan-uzundalsaglik.gov.tr

Bilimsel çalışmalar

Yayınlar

13 yayın

  1. Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

    Cancers, 2026

    DOI 10.3390/cancers18121979 PMID 42352512 Açık erişimli tam metinKaynak: OpenAlex

  2. Re: Three versus Six Cycles of Platinum-Based Chemotherapy Followed by Avelumab Maintenance as First-Line Treatment for Advanced Urothelial Cancer: The Phase II DISCUS Trial

    European Urology, 2026

    DOI 10.1016/j.eururo.2026.03.010 PMID 41925429 Kaynak: OpenAlex

  3. Lenvatinib Dose Intensity and Tumor Response in Renal Cell Carcinoma Considering Tumor Burden and Nephrectomy Timing

    2026

    DOI 10.1093/jjco/hyag195 Kaynak: ORCID

  4. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)

    Turkish Journal of Gastroenterology, 2025

    DOI 10.5152/tjg.2025.24784 PMID 40241388 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  5. Investigation of systemic treatment responses and prognostic factors in metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)

    Journal of Health Sciences and Medicine, 2025

    DOI 10.32322/jhsm.1744286 Açık erişimli tam metinKaynak: ORCID

  6. 2914eP Association between quality of life and sleep disturbances, anxiety, depression, and fatigue during and after (neo)adjuvant taxane-based chemotherapy in breast cancer patients

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3526 Açık erişimli tam metinKaynak: OpenAlex

  7. Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study

    Current Oncology, 2024

    DOI 10.3390/curroncol31110502 PMID 39590133 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  8. 1492P The role of LACE index in predicting 30-day unplanned readmission in patients receiving immunotherapy

    Annals of Oncology, 2024

    DOI 10.1016/j.annonc.2024.08.1557 Açık erişimli tam metinKaynak: ORCID

  9. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving Chemoimmunotherapy

    Expert Opinion on Pharmacotherapy, 2024

    DOI 10.1080/14656566.2024.2391007 PMID 39115275 4 atıf (Europe PMC) Kaynak: ORCID

  10. Quality and Reliability Analysis of Videos About Thulium Laser Enucleation of the Prostate on Youtube

    Urology, 2024

    DOI 10.1016/j.urology.2024.07.008 PMID 39002845 1 atıf (Europe PMC) Kaynak: ORCID

13 yayının tamamını gör